-
Oral Session IV B
Rita Lima-SousaDone
-
Openning Session
Done
-
Oral Session III B
Ana R. CostaDone
-
Enterprise Plenary Session I
Josué Carvalho (Ph.D.)Done
-
Plenary Session IV
Professor Jens PahnkeDone
-
Oral Session II A
Rita CarapitoDone
-
Hot Topics II: New biomolecules: Challenges in the development and clinical translation
Carlos Neto, PharmD: Medical Scientific Liaison at Angelini Pharma Portugal and Pedro Madureira, Co-founder and CSO at IMMUNETHEPDone
-
Enterprise Plenary Session III
Sofia Venceslau (Ph.D.)Done
-
Oral Session IV A
Nádia OliveiraDone
-
Coffee Break
Done
Flash Session I (A)
13/02/2023, 12:20
-
13/02/2023, 12:25
(UTC)
(5 minutes)
David Moreira
